CD4 and cancer: In general, a positive correlation was observed between NCBP2 and various immune cells, such as MDSC, progenitors of lymphoid, CD4+ T cell, CAF, neutrophils and monocytes, however a negative correlation was identified with NKT cells in various cancers (Fig. 5B).